1 / 11

China Cancer Drugs Market

Access full Research: <br><br>https://www.renub.com/china-cancer-drugs-market-p.php<br><br>Anti-Cancer drugs are the drugs which are used to reduce or prevent the cell proliferation of cancerous tissues. China Cancer Drugs Market is projected to reach US$ 30 Billion by the year 2024; owing to the increasing prevalence of various types of cancer, changing lifestyle & dietary habits, growing aging population, rising demand of targeted drug therapy and the patent expiration of key cancer drugs. Cancer is one of the leading causes of death worldwide and is a major public health burden in both developed and developing countries. <br>

renubresearch
Télécharger la présentation

China Cancer Drugs Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Category: Drugs & Pharmaceuticals Market Report

  2. China Cancer Drugs Market Analyst View: • China Cancer Drugs Market is projected to reach US$ 30 Billion by the year 2024. GetFree Customization in this Report • Research Report Title: • China Cancer Drugs Market, by Drugs [Cytotoxic Drugs (Antimetabolities, Plant Alkaloids, Alkylating Agents), Targeted Drugs, Monoclonal Antibiotics, Hormonal Drugs, Traditional Chinese Medicine (TCM), & Others], Cancer (Lung, Stomach, Breast, Esophageal, Liver & Others), Therapy (Chemotherapy, Targeted Therapy, Hormonal Therapy & Others), Companies (Merck, Celgene, Eli Lilly, Roche & Sino BioPharma) • Access Full Research:  • https://www.renub.com/china-cancer-drugs-market-p.php

  3. China Cancer Drugs Market is projected to reach US$ 30 Billion by the year 2024. Anti-Cancer drugs are the drugs which are used to reduce or prevent the cell proliferation of cancerous tissues. China Cancer Drugs Market is projected to reach US$ 30 Billion by the year 2024; owing to the increasing prevalence of various types of cancer, changing lifestyle & dietary habits, growing aging population, rising demand of targeted drug therapy and the patent expiration of key cancer drugs. Cancer is one of the leading causes of death worldwide and is a major public health burden in both developed and developing countries. The rate of cancer incidences in China is exploding very rapidly; nearly 4 million people diagnosed and almost 3 million died from it. For instance; due to increasing air pollution over the last couple of years, lung cancer has increased 50% in Beijing only. Anticancer drugs act like an inhibitor that prevents cancer cells to grow.

  4. China Cancer Drugs Market is projected to reach US$ 30 Billion by the year 2024. In addition; factors like growing awareness regarding cancer diagnosis & treatment, advancement in cancer drugs and therapies, rise in cancer awareness programs like breast cancer screening, investment in healthcare infrastructure are expected to drive China anti-cancer drugs market positively over the forecast period. However, major side-effects of cancer drugs and its high cost are certainly restraining the China anti-cancer drugs market to reach its full potential. Request a free sample copy of the report:https://www.renub.com/contactus.php Renub Research report titled “China Cancer Drugs Market, by Drugs [Cytotoxic Drugs (Antimetabolities, Plant Alkaloids, Alkylating Agents), Targeted Drugs, Monoclonal Antibiotics, Hormonal Drugs, Traditional Chinese Medicine (TCM), & Others], Cancer (Lung, Stomach, Breast, Esophageal, Liver & Others), Therapy (Chemotherapy, Targeted Therapy, Hormonal Therapy & Others), Companies (Merck, Celgene, Eli Lilly, Roche & Sino BioPharma)” provides a complete analysis of China Anti-Cancer Drugs Market.

  5. China Cancer Drugs Market is projected to reach US$ 30 Billion by the year 2024.

  6. China Cancer Drugs Market is projected to reach US$ 30 Billion by the year 2024. By Drugs – Cytotoxic Drugs leads the Cancer Drugs Market in China Based on the drugs type, China cancer drugs market is segmented into cytotoxic drugs, targeted drugs, Monoclonal Antibiotics, hormonal drugs, TCM and Others. The cytotoxic drugs segment is further classified into Antimetabolites, Plant Alkaloids and Alkylating Agents.  By Cancer – Lungs Cancer accounts for the largest share of China Cancer Drugs Market On the basis of cancer type, China cancer drugs market is segmented into Lung, Stomach, Breast, Esophageal, Liver & Others. Lung, Breast and Stomach Cancer dominates the China anti-cancer drugs market and is expected to do so in the near future.  By Therapy – Targeted Therapy is expected to grow significantly during the forecast period By therapy type, the China anti-cancer drugs market is segmented into chemotherapy, targeted therapy, hormonal therapy and others. Chemotherapy and targeted therapy together held the major share of China cancer drugs market. 

  7. China Cancer Drugs Market is projected to reach US$ 30 Billion by the year 2024. Company Analysis Some of the prominent companies competing in the China Anti-Cancer Drugs Market, and profiled in the report include Merck, Celegene, Eli Lilly, Roche and Sino BioPharma. This market research report provides a complete analysis of the China Cancer Drugs Market, Growth Drivers, Challenges, and their projections for the upcoming years. Client can Purchase this Report in Sections from below link: Access full Research: https://www.renub.com/china-cancer-drugs-market-p.php By Drugs •    Cytotoxic Drugs  o    Antimetabolities o    Plant Alkaloids oAlkylating Agents  •    Targeted Drugs •    Monoclonal Antibiotics •    Hormonal Drugs•    Traditional Chinese Medicine (TCM) •    Others

  8. China Cancer Drugs Market is projected to reach US$ 30 Billion by the year 2024. By Cancer •    Lung Cancer •    Stomach Cancer•    Breast Cancer •    Esophageal Cancer•    Liver Cancer •    Others By Therapy •    Chemotherapy •    Targeted Therapy•    Hormonal Therapy •    Others Companies Covered in the Report •    Merck •Celegene•    Eli Lilly •    Roche•    Sino BioPharma

  9. Table of Contents for China Cancer Drugs Market Key Topics Covered 1. Executive Summary 2.    China Cancer Drugs Market 3.    Market Share – China Anti-Cancer Drugs 3.1    By Drugs 3.2    By Cancer3.3    By Therapy 4.    Drugs – China Cancer Market 4.1    CytotoxicDrugs 4.2    Targeted Drugs4.3    Monoclonal Antibiotics 4.4    Hormonal Drugs4.5    Traditional Chinese Medicine 4.6Others 5.    Cancer Type – Market 5.1    Lung Cancer 5.2    Stomach Cancer5.3    Breast Cancer 5.4    Esophageal Cancer5.5    Liver Cancer 5.6    Others

  10. Table of Contents for China Cancer Drugs Market 6.    Therapy – China Cancer Market 6.1    Chemotherapy 6.2    Targeted Therapy6.3    Hormonal Therapy 6.4    Others 7.    Company Analysis 7.1    Merck 7.2Celgene 7.3    Eli Lilly 7.4    Roche 7.5    Sino BioPharma 8.    Growth Drivers 8.1    Growing Awareness towards Cancer Diagnosis and Treatment8.2    Increasing Use of Targeted Therapy8.3    Increasing Research and Development Activities8.4    Cutting Import Duties on Cancer Drugs 9.    Challenges 9.1    High Cost of Cancer Drugs9.2    Major Side Effects of Cancer Treatment

  11. GetFree Customization in this Report • Drugs & Pharmaceuticals Market Reports: • https://www.renub.com/drugs-and-pharmaceuticals-13-c.php

More Related